As featured on:
A multi-disciplinary team that has the expertise to solve complex problems, a passion to make a positive impact on our world, and a sense of urgency to bring hope to the human race.
fluidIQ, a public benefit and Delaware corporation, provides simple yet elegant solutions based on proprietary fluidics technology. The company was founded by a group of doctors, engineers and patient advocates who joined together to find solutions for gaps in medical needs, including ventilators, in the midst of the coronavirus-caused world crisis. fluidIQ aims to deliver hope to a world in need with simple, easy-to-deploy technology solutions that solve the most pressing medical challenges of our time. fluidIQ’s roadmap for an entire family of products is based on its proprietary platform of fluidics-operated devices dedicated to filling gaps in emergency and preparedness protocols that are user-friendly, scalable and cost-effective.
A team of emergency and respiratory doctors, patient advocates and engineers, who came together in the early days of the pandemic, founded fluidIQ a public benefit corporation (PBC) domiciled in Delaware. The unique group of experts joined informally in March 2020, to develop simple-to-use emergency devices that require no electricity, harness the science of fluidics and solve some the world’s most pressing problems. In fact, the company’s name, fluidIQ, is based on the concept of “fluid intelligence” described as “taking separate areas of expertise and applying them to new problems.”
fluidIQ is developing technologies that use clever design to direct airflow using a science called “fluidics” to operate without electricity. Fluidics uses the flows and pressures of fluids or air to control operations normally performed by battery powered or electronic devices, without moving parts or electricity.
fluidIQ’s first entrant will be in the medical space providing what they believe is the world’s smallest mechanical ventilation device, filling unmet clinical and safety needs in countries around the world. This handheld resuscitation device was designed to be well-suited for use by EMS and first responders, providing breathing assistance to patients who are struggling to breathe or providing full breathing support for patients who are not breathing on their own when emergency help arrives.
inVent™, a device the size of a tube of lipstick, is also designed to meet demands for limited weight, space and ruggedness in stockpiling for disaster preparedness.
In the words of our late founding CEO, Chris Jung, “Our multi-disciplinary team has the expertise to solve complex problems, a passion to make a positive impact on our world and a sense of urgency to bring hope to the human race.”
We are passionate about our work and committed to making a difference in the lives of people in crisis and those seeking to help them. We are inspired to boldly address gaps in medical need with a strong scientific curiosity and a commitment to be better humans every day.
To revolutionize medical care with elegant, low cost, effective devices that improve lives and save humanity.
The problem: The current standard of care in emergency resuscitation is a 70-year-old manual technology that requires both hands of the responder and has multiple other limitations, the most important of which is the inadvertent damage they can do to patients’ lungs.
The solution: Our lipstick-sized automatic resuscitator is aimed at disrupting the emergency medical space by improving the lives of patients in crisis with lung protective ventilation. We support emergency medical providers by freeing up their hands to manage multiple patient needs. The HOPE inVent provides a simple yet elegant breathing support solution that requires no electricity or batteries and can be used in even the most resource scarce environments.
Solid state uni-body design and operation with no moving parts.
Provides gas powered automatic resuscitation, controlled by fluidics with exceptional consistency and reliability.
Cannot be altered or adjusted and is not subject to failure due to springs and valves. Set by clinical design and tested at the point of manufacture.
Tri-Device system to target the needs of EMS first responders from overdose to severe ARDS
Designed is suited for globally distributed manufacturing needs
Developed by a multi-national team of experts driven by simplification to provide the highest level of patient lung care
Disclaimer: Pending US FDA 510(k) clearance. Not available for sale in the U.S.
“Alone, we can do so little. Together, we can do so much.” — Helen Keller
Our team of doctors, engineers, patient advocates and industry experts came together in the early days of the pandemic. Combined, we have 200 years of experience in life sciences, engineering, startups and exits, commercialization and execution. At this stage in a typical startup lifecycle, having a team with this depth and breadth is highly uncommon. Together, our team is bringing disruptive technology to the emergency medicine market and bringing HOPE to the world.
Chief Executive Officer
Chief Financial Officer
Chief Commercial Officer
Chief Technology Officer
Vice President Medical Affairs
Ph.D., RRT, FAARC, Chief of Clinical R&D
Lead Independent Board Of Directors
MD, Chief Medical Officer
2023 — The Index Project — fluidIQ named nominee for The Index Project 2023 Awards
LEWES, DE, USA, December 29, 2022 /EINPresswire.com/ — This time last year, a startup team of doctors, engineers and patient advocates were experiencing grief and uncertainty in the weeks following their founding CEO’s sudden death. Today, as they celebrate 2022 with a profound sense of accomplishment focused on the progress they have made, they make a toast to him.
LEWES, DE, USA, November 29, 2022 /EINPresswire.com/ — fluidIQ’s miniature ventilator is featured in the November 29th issue of the National Institutes of Health’s (NIH) Director’s Blog. Researchers in the NIH’s Clinical Center or the hospital of the NIH have been researching the technology since the beginning of the pandemic and recently published their first scientific paper on it in Science Translational Medicine.
James K. Gilman, MD, NIH Clinical Center — Here at the NIH Clinical Center, we are proud to be considered a world-renowned research hospital that provides hope through pioneering clinical research to improve human health. But what you may not know is that our doctors are constantly partnering with public and private sectors to come up with innovative technologies that will help to advance health outcomes.
November 22, 2022 — An idea born out of the ventilator shortages from the COVID-19 pandemic is onto the next step to possibly being approved for widespread medical use.
LEWES, DE, USA, October 14, 2022 /EINPresswire.com/ — — fluidIQ, a startup MedTech company developing fluidics-based respiratory solutions, shared positive study results of a large animal study using their in-line 3D-printed ventilator, performed by the National Institutes of Health (NIH) Clinical Center that has been published in the journal, Science Translational Medicine.